Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.

Jang J, Kwok B, Zhong H, Xia Y, Grucela A, Bernstein M, Remzi F, Hudesman D, Chen J, Axelrad J, Chang S.

Dig Dis Sci. 2019 Sep 14. doi: 10.1007/s10620-019-05839-5. [Epub ahead of print]

PMID:
31522323
2.

Does alvimopan enhance return of bowel function in laparoscopic right colectomy?

Abodeely A, Schechter S, Klipfel A, Vrees M, Lagares-Garcia J.

Am Surg. 2011 Nov;77(11):1460-2.

PMID:
22196657
3.

Role of alvimopan (entereg) in gastrointestinal recovery and hospital length of stay after bowel resection.

Wang S, Shah N, Philip J, Caraccio T, Feuerman M, Malone B.

P T. 2012 Sep;37(9):518-25.

4.

Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.

Lee CT, Chang SS, Kamat AM, Amiel G, Beard TL, Fergany A, Karnes RJ, Kurz A, Menon V, Sexton WJ, Slaton JW, Svatek RS, Wilson SS, Techner L, Bihrle R, Steinberg GD, Koch M.

Eur Urol. 2014 Aug;66(2):265-72. doi: 10.1016/j.eururo.2014.02.036. Epub 2014 Feb 26.

PMID:
24630419
5.

Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.

Wolff BG, Weese JL, Ludwig KA, Delaney CP, Stamos MJ, Michelassi F, Du W, Techner L.

J Am Coll Surg. 2007 Apr;204(4):609-16.

PMID:
17382220
6.

Management of postoperative ileus: focus on alvimopan.

Marderstein EL, Delaney CP.

Ther Clin Risk Manag. 2008 Oct;4(5):965-73.

7.

Alvimopan for the management of postoperative ileus.

Leslie JB.

Ann Pharmacother. 2005 Sep;39(9):1502-10. Epub 2005 Aug 2. Review.

PMID:
16076918
8.

Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.

Delaney CP, Weese JL, Hyman NH, Bauer J, Techner L, Gabriel K, Du W, Schmidt WK, Wallin BA; Alvimopan Postoperative Ileus Study Group.

Dis Colon Rectum. 2005 Jun;48(6):1114-25; discussion 1125-6; author reply 1127-9.

PMID:
15906123
9.

Pharmacologic options to prevent postoperative ileus.

Yeh YC, Klinger EV, Reddy P.

Ann Pharmacother. 2009 Sep;43(9):1474-85. doi: 10.1345/aph.1M121. Epub 2009 Jul 14. Review.

PMID:
19602600
10.

Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.

Wolff BG, Michelassi F, Gerkin TM, Techner L, Gabriel K, Du W, Wallin BA; Alvimopan Postoperative Ileus Study Group.

Ann Surg. 2004 Oct;240(4):728-34; discussion 734-5.

11.

Does alvimopan enhance return of bowel function in laparoscopic gastrointestinal surgery? A meta-analysis.

Nguyen DL, Maithel S, Nguyen ET, Bechtold ML.

Ann Gastroenterol. 2015 Oct-Dec;28(4):475-80.

12.

Delayed gastrointestinal recovery after abdominal operation - role of alvimopan.

Berger NG, Ridolfi TJ, Ludwig KA.

Clin Exp Gastroenterol. 2015 Aug 5;8:231-5. doi: 10.2147/CEG.S64029. eCollection 2015. Review.

13.

Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study.

B├╝chler MW, Seiler CM, Monson JR, Flamant Y, Thompson-Fawcett MW, Byrne MM, Mortensen ER, Altman JF, Williamson R.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):312-25.

14.

Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.

Earnshaw SR, Kauf TL, McDade C, Potashman MH, Pauyo C, Reese ES, Senagore A.

J Am Coll Surg. 2015 Nov;221(5):941-50. doi: 10.1016/j.jamcollsurg.2015.08.004. Epub 2015 Aug 15.

PMID:
26353904
15.

Alvimopan addition to a standard perioperative recovery pathway.

Itawi EA, Savoie LM, Hanna AJ, Apostolides GY.

JSLS. 2011 Oct-Dec;15(4):492-8. doi: 10.4293/108680811X13176785204076.

16.

Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway.

Ludwig K, Enker WE, Delaney CP, Wolff BG, Du W, Fort JG, Cherubini M, Cucinotta J, Techner L.

Arch Surg. 2008 Nov;143(11):1098-105. doi: 10.1001/archsurg.143.11.1098.

PMID:
19015469
17.

Alvimopan in the setting of colorectal resection with an ostomy: To use or not to use?

Wen Y, Jabir MA, Keating M, Althans AR, Brady JT, Champagne BJ, Delaney CP, Steele SR.

Surg Endosc. 2017 Sep;31(9):3483-3488. doi: 10.1007/s00464-016-5373-0. Epub 2016 Dec 7.

PMID:
27928668
18.

Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.

Hilton WM, Lotan Y, Parekh DJ, Basler JW, Svatek RS.

BJU Int. 2013 Jun;111(7):1054-60. doi: 10.1111/j.1464-410X.2012.11499.x. Epub 2012 Nov 21.

19.

Alvimopan: a peripherally acting mu-opioid receptor antagonist.

Leslie JB.

Drugs Today (Barc). 2007 Sep;43(9):611-25. Review.

PMID:
17940638
20.

Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.

Viscusi ER, Goldstein S, Witkowski T, Andonakakis A, Jan R, Gabriel K, Du W, Techner L, Wallin B.

Surg Endosc. 2006 Jan;20(1):64-70. Epub 2005 Dec 7. Erratum in: Surg Endosc. 2006 Mar;20(3):537.

PMID:
16333556

Supplemental Content

Support Center